Agriculture, Construction, Foodstuff, Good for Business, Investments, Latvia, Markets and Companies
International Internet Magazine. Baltic States news & analytics
Thursday, 28.03.2024, 12:28
Mesako to build tiger prawn farm in Sigulda municipality for EUR 5 mln
BC, Riga, 07.01.2020.Print version
Mesako construction firm will build a tiger prawn farm for APGE company in the Sigulda municipality for EUR 5 mln, according to information available on the Public Procurement Monitoring Bureau's website, writes LETA.
Masako beat two rival companies to win the APGE tender for the right to build the tiger prawn farm and provide it with the necessary equipment. The price of the contract is EUR 4.861 mln, excluding value added tax (VAT).
The project, which will be implemented on Jaunanneni farm in Sigulda municipality, is scheduled for completion by December 30, 2021. APGE hopes to raise co-funding from the European Maritime and Fisheries Fund's (EMFF) program Productive Investments in Aquaculture.
APGE plans to sell tiger prawns in Latvia and neighbor countries.
According to Firmas.lv, APGE was registered in 2017, its share capital is EUR 210,000. APGE belongs to Swedish company Mesako AB (94.97%), Elizabete Baltina (4.76%) and Maris Hmelnickis (0.27%).
Other articles:
- 28.01.2022 BONO aims at a billion!
- 26.08.2021 LLC Dizozols Investments finalizes investment attraction deal with Crowdestor with record-high profits
- 13.02.2021 Моя жизнь в газете. Очерки по новейшей истории Латвии. Глава 1
- 25.01.2021 Как банкиры 90-х делили «золотую милю» в Юрмале
- 30.12.2020 Накануне 25-летия Балтийский курс/The Baltic Course уходит с рынка деловых СМИ
- 30.12.2020 On the verge of its 25th anniversary, The Baltic Course leaves business media market
- 30.12.2020 Business Education Plus предлагает анонсы бизнес-обучений в январе-феврале 2021 года
- 30.12.2020 Hotels showing strong interest in providing self-isolation service
- 30.12.2020 EU to buy additional 100 mln doses of coronavirus vaccine
- 30.12.2020 ЕС закупит 100 млн. дополнительных доз вакцины Biontech и Pfizer